Pure Global AI
NCT06381804Recruiting

Effect of Shotblocker and Palm Stimulator

Effect of Shotblocker and Palm Stimulator in Reducing Pain Associated With Intramuscular Injection: A Randomized Controlled Trial
Necmettin Erbakan UniversityClinicalTrials.govother
Verified
Study focus
Disease/Condition
Pain
Drug/Device/Intervention
shotblocker
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Necmettin Erbakan University
Location
Meram, Turkey
Timeline & enrollment
Phase
N/A
Start date
Apr 19, 2024
End date
May 01, 2024
Enrollment
96 participants
Primary outcome

Visual analog scale (VAS) pain Scale score

Summary

This study discusses the advancements in nursing, particularly focusing on intramuscular
 injections, their complications, and innovative non-pharmacological methods such as the
 Shotblocker and palm stimulator to reduce pain. These methods, based on the gate control
 theory, aim to minimize discomfort during injections by applying tactile stimulation, which
 has proven effective in various studies.

ICD-10 classifications
Pain, unspecifiedPain, not elsewhere classifiedPain in limbAcute painOther chronic pain
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06381804
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06381804 through Pure Global AI's free database. This phase not specified trial is sponsored by Necmettin Erbakan University and is currently Recruiting. The study focuses on Pain. Target enrollment is 96 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.